• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center
eNews, DF/HCC's online quarterly newsletter, highlights the groundbreaking research, news, and events taking place within DF/HCC, and showcases the services and tools DF/HCC offers to facilitate collaboration and discovery in the Harvard community.
Calendar

Welcome to Dana-Farber/Harvard Cancer Center

Dana-Farber/Harvard Cancer Center (DF/HCC) is the largest comprehensive cancer center in the world, bringing together the cancer research efforts of our seven member institutions: Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health, and Massachusetts General Hospital.

Funded by a grant from the National Cancer Institute, we have joined these seven renowned Harvard-affiliated medical centers into one collective force dedicated to the fight against cancer. Based in Boston, DF/HCC consists of more than 1,000 researchers with a singular goal -- to find new and innovative ways to combat cancer.


Latest Cancer News

    DF/HCC Members Presented with 2014 AACR Awards

    April 14, 2014 Congratulations to Levi Garraway and Rakesh Jain, who were among the 2014 American Association for Cancer Research (AACR) awardees: Levi Garraway (DFCI) was... | [more]

    Bromodomain Inhibition: Helping Cancer Cells “Forget”

    April 2014 | eNews The TPETT program, with its mission to facilitate the development of new anticancer agents from the preclinical to the clinical stages, relies on basic... | [more]

    DF/HCC TPETT Program: Testing novel therapeutics in phase I and II trials

    April 2014 | eNews As researchers delve ever deeper into the underpinnings of cancer biology, more therapeutic targets emerge; targets that, when attacked, will in theory... | [more]